(4aS,9bR)-Ethyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate
97%
- Product Code: 113332
CAS:
2098497-32-4
Molecular Weight: | 396.28 g./mol | Molecular Formula: | C₁₇H₂₂BrN₃O₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD30730054 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature, dry and sealed |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the study of neurological disorders. Its structure suggests potential activity as a modulator of specific receptor systems in the brain, making it valuable for investigating treatments for conditions like depression, anxiety, or schizophrenia. Researchers often employ it in preclinical studies to evaluate its efficacy and safety profile. Additionally, it may serve as an intermediate in the synthesis of more complex molecules targeting central nervous system pathways. Its unique chemical framework allows for exploration in drug discovery programs aimed at developing novel therapeutic agents.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | $97.64 |
+
-
|
0.250 | 10-20 days | $174.94 |
+
-
|
(4aS,9bR)-Ethyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate
This compound is primarily utilized in pharmaceutical research and development, particularly in the study of neurological disorders. Its structure suggests potential activity as a modulator of specific receptor systems in the brain, making it valuable for investigating treatments for conditions like depression, anxiety, or schizophrenia. Researchers often employ it in preclinical studies to evaluate its efficacy and safety profile. Additionally, it may serve as an intermediate in the synthesis of more complex molecules targeting central nervous system pathways. Its unique chemical framework allows for exploration in drug discovery programs aimed at developing novel therapeutic agents.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :